Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fieldstone Bio has developed a synthetic biology-based platform that programs microbes to act as living sensors for detecting specific chemicals in the environment. These engineered microbes change color upon encountering target substances such as pollutants or explosives. The signals are then detected remotely via drones, planes, or satellites using hyperspectral imaging and analyzed with AI to produce high-resolution chemical maps. The technology is currently transitioning from laboratory validation to real-world field testing after raising $5 million in seed funding. No clinical results apply.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fieldstone Bio.